NVZMY : Summary for NOVOZYMES A/S ADR EACH REP 1 SE - Yahoo Finance

U.S. Markets close in 2 hrs 26 mins

Novozymes A/S (NVZMY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
32.62-0.35 (-1.06%)
As of 1:17 PM EST. Market open.
People also watch:
NVZMFSGSOYLRLCYDYAICFRUY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close32.97
Open32.71
Bid0.00 x
Ask0.00 x
Day's Range32.42 - 32.71
52 Week Range32.42 - 49.55
Volume47,597
Avg. Volume28,234
Market Cap10.24B
Beta1.14
PE Ratio (TTM)23.88
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.51 (1.55%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Novozymes A/S :NVZMY-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
    Capital Cubelast month

    Novozymes A/S :NVZMY-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016

    Categories: Yahoo Finance Get free summary analysis Novozymes A/S reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Novozymes A/S – Innophos Holdings, Inc., Procter & Gamble Company and E. I. du Pont de Nemours and Company (IPHS-US, PG-US and DD-US) that have also reported for this ... Read more (Read more...)

  • Novozymes A/S : Neutral price; Buy/ Sell depends on fundamentals
    Capital Cubelast month

    Novozymes A/S : Neutral price; Buy/ Sell depends on fundamentals

    Categories: Yahoo Finance Novozymes A/S relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 81. Our analysis is based on comparing Novozymes A/S with the following peers – Innophos Holdings, Inc., Codexis, Inc., Procter & Gamble Company, E. I. du Pont de Nemours and Company and Syngenta AG Sponsored ADR ... Read more (Read more...)

  • Market Realistlast month

    Did Portfolio Shuffling Help the Fidelity Advisor Europe Fund in 2016?

    The Fidelity Advisor Europe Fund – Class A (FHJUX) has been an above-average performer in YTD 2016, ranking third in the one-year period ended October 21, 2016.